Tozadenant (INN, USAN; developmental code names RO4494351 and SYN-115) is an adenosine A2A receptor antagonist which was under development for the treatment of Parkinson's disease and liver disorders but was never marketed due to safety concerns.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.